Jeuveau is FDA-approved specifically for moderate to severe glabellar lines (the 11s), and many patients notice a quicker onset than with traditional options thanks to its Hi Pure technology
EPA and DHA support cardiovascular health, brain function, and have anti-inflammatory properties that could benefit GLP-1 users dealing with inflammation-related side effects
There are numerous explanations for it
Helps with weight-related goals: Clinical studies, such as the OASIS 1 trial, have shown significant weight loss in individuals taking oral semaglutide (at doses higher than what is currently approved), including those without type 2 diabetes
This strategy not only enhances adherence to treatment but also helps control healthcare costs, leading to improved patient outcomes
Another 29% of GLP-1 users said they feel more confident in social settings, 25% are more comfortable experimenting with their overall look and 21% are more aware of their grooming or self-care routine